Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · May 30, 2023

CD27-Positive B-Cell Count Monitoring and Rituximab Dosing in Patients With NMOSD and MOGAD

Neurology and Therapy


Additional Info

Disclosure statements are available on the authors' profiles:

Neurology and Therapy
Tailoring Rituximab According to CD27-Positive B-Cell versus CD19-Positive B-Cell Monitoring in Neuromyelitis Optica Spectrum Disorder and MOG-Associated Disease: Results from a Single-Center Study
Neurol Ther 2023 May 11;[EPub Ahead of Print], N Bruschi, M Malentacchi, S Malucchi, F Sperli, S Martire, A Sala, P Valentino, A Bertolotto, M Pautasso, MA Capobianco

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading